Remediation of a hydrocarbon producing well bore in a subterranean formation includes injecting fluid containing self-degrading particulates into the well bore in order to stop production of hydrocarbon from the well bore prior to commencement of remedial operations and to temporarily seal the well bore from fluid transmission between the well bore and the formation prior to commencement of the remedial operations, and commencing the remedial operations upon the well bore. Examples of the remedial operations include injecting weighted fluid into the well bore, inserting a down-hole tool into the well bore, casing treatment, annulus treatment, well bore wall treatment, cementing, and refracturing. For refracturing, the fluid containing the self-degrading particulates can be injected until a down-hole pressure exceeds a fracture breakdown pressure of new fractures that will be produced by a perforating tool lowered into the well bore.

The present invention relates to a method for sealing and/or consolidating a subterranean formation, wherein a gelling aqueous solution comprising an alkaline solution of potassium silicate, acetic acid and an aluminate is prepared and injected into the subterranean formation.

The present invention relates to a method for sealing and/or consolidating a subterranean formation, wherein a gelling aqueous solution comprising an alkaline solution of potassium silicate, acetic acid and an aluminate is prepared and injected into the subterranean formation.

An aqueous oil-in-water emulsion containing a propylethoxysilane oligomer mixture or a mixture of a propylethoxysilane oligomer mixture and octyltriethoxysilane in a weight ratio of 3:1 to 1:3, at least one emulsifier or an emulsifier system, at least one content of a 2-aminoethanol and water is used as an addition in the production of hydraulically setting cement mixtures such as mortar, screed or concrete for reduction of the shrinkage characteristics.

An aqueous oil-in-water emulsion containing a propylethoxysilane oligomer mixture or a mixture of a propylethoxysilane oligomer mixture and octyltriethoxysilane in a weight ratio of 3:1 to 1:3, at least one emulsifier or an emulsifier system, at least one content of a 2-aminoethanol and water is used as an addition in the production of hydraulically setting cement mixtures such as mortar, screed or concrete for reduction of the shrinkage characteristics.

The present invention refers to a process for making a calcium carbonate containing material, wherein the process includes a specific drying procedure and allows for the provision of calcium carbonate materials with reduced moisture pick-up and low porosity.

The present invention refers to a process for making a calcium carbonate containing material, wherein the process includes a specific drying procedure and allows for the provision of calcium carbonate materials with reduced moisture pick-up and low porosity.

The present invention relates to a carbonic acid adduct (CAA) comprising carbonic acid, at least one amine, and optionally at least one salt, said adduct being producible by a method comprising the following steps: a) providing a solution (A) comprising dissolved CO.sub.2; optionally b) dissolving a base (BA) not corresponding to the amine (AM) in the solution (A) so as to obtain the solution (A1); c) dissolving the at least one amine (AM) in the solution (A) or (A1) so as to obtain the solution (B); d) freezing the solution obtained after completion of step c); and e) storing the solution frozen in step d) at −100 to 0° C. for no longer than 4 days. The content of CO.sub.2 in the solution that is subjected to step c) is at least 6 g/l. The invention also relates to a method for producing the carbonic acid adduct (CAA), a pharmaceutical preparation (PP) comprising the carbonic acid adduct (CAA), and methods for the production thereof and use of the carbonic acid adduct (CAA) or the pharmaceutical preparation (PP) in therapy for a range of indications.

The present invention relates to a carbonic acid adduct (CAA) comprising carbonic acid, at least one amine, and optionally at least one salt, said adduct being producible by a method comprising the following steps: a) providing a solution (A) comprising dissolved CO.sub.2; optionally b) dissolving a base (BA) not corresponding to the amine (AM) in the solution (A) so as to obtain the solution (A1); c) dissolving the at least one amine (AM) in the solution (A) or (A1) so as to obtain the solution (B); d) freezing the solution obtained after completion of step c); and e) storing the solution frozen in step d) at −100 to 0° C. for no longer than 4 days. The content of CO.sub.2 in the solution that is subjected to step c) is at least 6 g/l. The invention also relates to a method for producing the carbonic acid adduct (CAA), a pharmaceutical preparation (PP) comprising the carbonic acid adduct (CAA), and methods for the production thereof and use of the carbonic acid adduct (CAA) or the pharmaceutical preparation (PP) in therapy for a range of indications.

Magnesium phosphate cement binder systems and method for providing magnesium phosphate cements are described. In an embodiment, a magnesium phosphate cement binder system may include magnesium oxide that has been calcined at a temperature of between about 900° F. to about 1800° F. The magnesium phosphate cement binder system may also include a phosphate material. Other formulations, compositions, and methods are also described.